0001562180-21-007900.txt : 20211229
0001562180-21-007900.hdr.sgml : 20211229
20211229171929
ACCESSION NUMBER: 0001562180-21-007900
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211206
FILED AS OF DATE: 20211229
DATE AS OF CHANGE: 20211229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horstmeier Paul
CENTRAL INDEX KEY: 0001780978
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38993
FILM NUMBER: 211529774
MAIL ADDRESS:
STREET 1: C/O HEALTH CATALYST, INC.
STREET 2: 3165 E. MILLROCK DRIVE #400
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Health Catalyst, Inc.
CENTRAL INDEX KEY: 0001636422
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 453337483
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
BUSINESS PHONE: 801-708-6800
MAIL ADDRESS:
STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
FORMER COMPANY:
FORMER CONFORMED NAME: HQC Holdings, Inc.
DATE OF NAME CHANGE: 20150312
4/A
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4/A
2021-12-06
2021-12-07
false
0001636422
Health Catalyst, Inc.
HCAT
0001780978
Horstmeier Paul
C/O HEALTH CATALYST, INC.
10897 SOUTH RIVER FRONT PARKWAY, #300
SOUTH JORDAN
UT
84095
false
true
false
false
Chief Operating Officer
Common Stock
2021-12-06
4
M
false
6063.00
15.84
A
105243.00
D
Common Stock
2021-12-06
4
S
false
600.00
37.9667
D
104643.00
D
Common Stock
2021-12-06
4
S
false
2674.00
38.76
D
101969.00
D
Common Stock
2021-12-06
4
S
false
2789.00
39.8888
D
99180.00
D
Stock Option (Right to Buy)
15.84
2021-12-06
4
M
false
6063.00
0.00
D
2029-02-05
Common Stock
6063.00
52028.00
D
Due to a technical and administrative error, the original Form 4, filed on December 7, 2021, incorrectly reflected a sale of shares of Common Stock by the Reporting Person attributed to a vesting of Restricted Stock Units. We were recently made aware that the Reporting Person exercised options and sold shares from that option exercise. The exercise of those options and sale of shares is correctly reflected herein and the correct ownership tabulations are also included herein.
The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2020, in accordance with Rule 10b5-1.
Represents the weighted average sale price of the shares sold ranging from $37.47 to $38.43 per share, inclusive.
Represents the weighted average sale price of the shares sold ranging from $38.47 to $39.24 per share, inclusive.
Represents the weighted average sale price of the shares sold ranging from $39.66 to $40.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (3) through (5).
25% of the 186,467 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.
/s/ Daniel Orenstein, as Attorney-in-Fact
2021-12-29